Photosensitivity, or skin sensitivity to ultraviolet radiation (UVR), is a feature of lupus erythematosus and other autoimmune and dermatologic conditions, but the mechanistic underpinnings are poorly understood. We identify a Langerhans cell (LC)-keratinocyte axis that limits UVR-induced keratinocyte apoptosis and skin injury via keratinocyte epidermal growth factor receptor (EGFR) stimulation. We show that the absence of LCs in Langerin-diphtheria toxin subunit A (DTA) mice leads to photosensitivity and that, in vitro, mouse and human LCs can directly protect keratinocytes from UVR-induced apoptosis. LCs express EGFR ligands and a disintegrin and metalloprotease 17 (ADAM17), the metalloprotease that activates EGFR ligands. Deletion of ADAM17 from LCs leads to photosensitivity, and UVR induces LC ADAM17 activation and generation of soluble active EGFR ligands, suggesting that LCs protect by providing activated EGFR ligands to keratinocytes. Photosensitive systemic lupus erythematosus (SLE) models and human SLE skin show reduced epidermal EGFR phosphorylation and LC defects, and a topical EGFR ligand reduces photosensitivity. Together, our data establish a direct tissue-protective function for LCs, reveal a mechanistic basis for photosensitivity, and suggest EGFR stimulation as a treatment for photosensitivity in lupus erythematosus and potentially other autoimmune and dermatologic conditions.
INTRODUCTION
Photosensitivity, a sensitivity to ultraviolet radiation (UVR) whereby even ambient sunlight exposure can result in inflammatory skin lesions, is a common feature in cutaneous and systemic forms of lupus ery thematosus and can also occur with other autoimmune conditions, a number of dermatologic conditions, and as a response to drugs such as fluoroquinolone antibiotics (1) (2) (3) . The photosensitive lesions can be disfiguring and, in systemic lupus erythematosus (SLE), can be associated with systemic disease flares (1, 2) . The pathogenesis of photosensitivity is poorly understood, and treatments consist mainly of sun avoidance and sunscreen to prevent lesion development (2) . A better understanding of the mechanistic basis of photosensitivity could lead to improved disease treatment.
Keratinocyte apoptosis occurs rapidly after UVR exposure, and photosensitivity is associated with increased keratinocyte apoptosis (4, 5) . In autoimmune diseases, apoptotic keratinocytes can display autoantigens that bind autoantibodies, leading to complement activa tion and sustained skin inflammation (1, 5) . The localization of "sunburn cells," or apoptotic keratinocytes, with lupus erythematosus skin lesions (6) further supports the idea that keratinocyte apoptosis is part of the pathophysiology. Keratinocytes are critical for normal skin barrier function (7) , and even in the absence of autoimmunity, increased keratinocyte death and failure to compensate have the potential to lead to skin injury and inflammation (8) . However, mechanisms that limit UVRinduced keratinocyte apoptosis that are dysfunctional in photo sensitivity are not well understood.
In addition to keratinocytes, the epidermis contains a popula tion of welldescribed Langerin + dendritic antigenpresenting cells, known as Langerhans cells (LCs). LCs are primarily associated with their antigen presentation functions: capturing antigens in the epidermis, migrating from the skin to the draining lymph node, and initiating T cell responses (9, 10) . In lupus skin lesions, LCs have an abnormal morphology and are reduced in number (11) , suggesting the possibility of a regulatory role. However, in the MRLFas lpr SLE mouse model, the role of LCs in spontaneous (that is, nonUVR-induced) skin lesion development has been examined with mixed conclusions; constitutive LC absence had no effect on skin lesions (12) , whereas acute depletion of LCs and Langerin + dermal dendritic cells (DCs) increased lesions, and this was attributed to loss of T cell tolerance (13) . Thus, the role of LCs in photo sensitivity and as a potential direct modulator of keratinocyte function has not been explored.
We and others have recently shown that DCs can directly modulate stromal elements in lymph nodes, adipose tissues, and skin (14) (15) (16) (17) (18) . Because LCs have DC characteristics (9, 10) , we asked whether LCs modulated keratinocyte survival and skin injury after UVR exposure.
Here, we delineate an LCkeratinocyte axis whereby LCs limit UVR induced kerat inocyte apoptosis and skin injury by ac tivating epidermal growth factor receptor (EGFR). This axis is dysfunctional in photo sensitive SLE mouse models, and there is also evidence of dysfunction in human SLE. Photosensitivity in one of the SLE models is reduced by EGFR ligand sup plementation. Together, our results iden tify a tissueprotective function for LCs, provide insight into mechanisms that limit skin injury, and suggest that EGFR stimulation may be an approach for treat ment of photosensitivity in lupus ery thematosus and other diseases.
RESULTS

LCs limit UVR-induced keratinocyte apoptosis and skin injury
LCs are positioned within the epidermis with keratinocytes (fig. S1, A and B), suggesting that LCs have the potential to modulate UVRinduced keratinocyte apoptosis. To test this idea, we used the Langerin-diphtheria toxin subunit A (DTA) mouse model that is constitu tively depleted of LCs (fig. S1C) but not of Langerin + dermal DCs (19) . We treated wildtype (WT) and LangerinDTA mice with UVR and examined the skin at 24 hours (Fig. 1A) . In WT mice, epider mal LCs were reduced by half with UVR ( fig. S1C ), likely due to LC emigration (9, 10) . As expected, UVR induced an in crease in activated caspase3 + cells in the epidermis (Fig. 1B, left) . These cells were Langerin − ( fig. S1D ) and CD3 − (fig. S1E), consistent with the idea that the apop totic cells were keratinocytes. The lack of activated caspase3 + Langerin + cells also suggested that LCs were not ingest ing apoptotic keratinocytes. Langerin DTA mice showed increased numbers of activated caspase3 + keratinocytes relative to WT mice (Fig. 1B, right) , and this oc curred as early as 3 hours after UVR ex posure (fig. S1F). LangerinDTA mice had greater monocyte accumulation (Fig. 1C) . This was associated with greater num bers of monocytederived DCs ( fig. S1G ), whereas CD11b − DCs, CD11b + DCs, macrophages, and neutrophils did not increase in LangerinDTA mice (fig. S1G). Our UVR source provided both ultravio let A and B radiation (20) , and increased UVRinduced keratinocyte apoptosis and monocyte accumulation in LangerinDTA and activated caspase-3 (green) stain. Right: Quantification (n = 3 to 9 mice). Scale bars, 50 m. (C) Absolute (left) and normalized (right) monocyte numbers assessed by flow cytometry (n = 3 to 7 mice ). (D) Experimental scheme for (E) and (F); ears were harvested 5 days (d5) after UVR. (E) Epidermal thickness (n = 3 to 7 mice). (F) Epidermal permeability as assessed by toluidine blue penetrance. Left: Representative images. Right: Quantification (n = 3 to 5 mice). (G) Experimental scheme for (H); mice were exposed to UVR for 3 days and examined 24 hours later. (H) Left: Representative images of back skin. Right: Lesional area quantification (n = 3 to 5 mice). Bars represent means (B, C, F, and H) or medians (E). Error bars depict SDs (B, C, F, and H) or interquartile ranges (E). *P < 0.05, **P < 0.01, ***P < 0.001 using two-tailed unpaired Student's t test (B, C, F, and H) or nonparametric nondirectional Mann-Whitney U test (E) after one-way analysis of variance (ANOVA). Data are from nine (B), five (C), four (E), two (F), and three (H) independent experiments.
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mice remained when UVB was blocked by use of a Mylar filter (fig. S1, H to J), suggesting that LCs limit the effects of, at least, UVA. Together, these results suggested that LCs limit UVRinduced kera tinocyte apoptosis and skin inflammation.
We assessed additional parameters of skin function. UVR exposure induces epidermal hyperplasia within several days (21) , and Langerin DTA mice showed less epidermal thickening than WT mice (Fig. 1, D and E). Epidermal barrier function is compromised despite the hyper plasia (22) , and LangerinDTA skin showed greater tissue penetrance of toluidine blue (23) than WT skin (Fig. 1F) , suggesting worsened barrier function. Consistent with worsened skin function, Langerin DTA mice showed a greater lesional area after exposure to multiple UVR doses (Fig. 1, G and H, and fig. S1K ). These results together suggested that LCs limit the extent of UVRinduced skin injury.
We next attempted to assess whether the monocytes that ac cumulated in UVRtreated skin contributed to the UVRinduced damage. Consistent with the work of Tamoutounour + DCs, these data raise the possibility that an increased number of infiltrating monocytes and monocytederived cells contributed to the worsened barrier func tion in LangerinDTA mice.
LCs directly protect keratinocytes
T cells also inhabit the epidermis ( Fig. 2A) (Fig. 2C) . These results suggested that LC mediated skin protection was independent of antigen presentation to T cells and that LCs could potentially limit keratinocyte apoptosis directly.
We tested for direct LCkeratinocyte interactions using LC keratinocyte cocultures. UVR induces keratinocyte apoptosis in vitro (26) , and addition of LCs reduced the apoptosis (Fig. 2, D and E) . Essentially, no activated caspase3 + cells were Langerin + ( fig. S3A ), suggesting that the LCmediated reduction in apoptotic keratino cytes was not due to apoptotic keratinocyte ingestion and clearance. These effects were not due to phototoxicity from the phenol redcontaining culture medium because results were similar in phenol red-free medium ( fig. S3B ). Together, these results suggested that LCs limit UVRinduced keratinocyte apoptosis and skin injury in vivo by direct interactions with keratinocytes.
LCs limit UVR-induced keratinocyte apoptosis and skin injury by stimulating epidermal EGFR Because keratinocyte EGFR signaling protects against UVRinduced keratinocyte apoptosis (21, 27) and contributes to maintaining epider mal barrier function and limiting skin inflammation (7, 28) , we hypoth esized that the LCmediated skin protection involved EGFR signaling. Treatment of WT mice with PD168393, an irreversible EGFR inhib itor (29) , reduced epidermal EGFR phosphorylation at tyrosine 1068 ( fig. S4, A and B) , a residue associated with keratinocyte survival after UVR (27) and E) independent experiments. Scale bars, 50 m. (B, C, and E) Bars represent means. Error bars depict SDs. *P < 0.05, **P < 0.01, ***P < 0.001 using two-tailed unpaired Student's t test after one-way ANOVA.
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signaling. EGFR inhibition led to increased UVRinduced keratino cyte apoptosis and skin injury ( fig. S4 , E to H), resembling results from LangerinDTA mice and supporting the idea that LCs may limit UVR induced skin injury by modulating keratinocyte EGFR signaling. We then examined the effects of LC absence on UVRinduced keratinocyte epidermal EGFR activation. EGFR showed increased phosphoryla tion by 1 hour after UVR exposure ( fig. S4I ) (21), so we assessed this time point in subsequent experiments. The epi dermis from LangerinDTA mice had a modest reduction in homeostatic EGFR phosphorylation (Fig. 3A) , and phos phorylation was not upregulated after UVR (Fig. 3B) . These results suggested that LCs mediated the UVR induced keratinocyte EGFR activation.
We asked whether the LCdependent EGFR stimulation was protective for ke ratinocytes. Treatment of LangerinDTA mice with heparinbinding EGFlike growth factor (HBEGF), a potent EGFR ligand (30) , reduced UVRinduced apop totic keratinocyte and monocyte accu mulation ( Together, these results suggested that LCs limit UVRinduced keratinocyte apop tosis and skin inflammation by stimu lating keratinocyte EGFR.
LC ADAM17 is critical for limiting photosensitivity and is activated by UVR
We asked whether LCs could be a key source of EGFR ligands. Both murine and human LCs expressed multiple EGFR ligands, such as epigen and am phiregulin, which were upregulated by UVR exposure in murine LCs (Fig. 4 , A and B). A dis integrin and metalloprotease 17 (ADAM17) is a membraneassociated metalloprotease that is necessary for the cleavage and activation in cis of all EGFR ligands except EGF and cellulin (31), the two ligands not expressed or minimally expressed by LCs ( , and three (E) independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 using two-tailed unpaired Student's t test. Student's t test was performed after one-way ANOVA for (B) to (G).
LC numbers (Fig. 4C ), LCAd17 mice showed reduced UVRinduced epidermal EGFR phosphorylation (Fig. 4D) , suggesting that LC derived ADAM17 was important for UVRinduced keratinocyte EGFR activation.
We further asked about the importance of LC ADAM17 in pro tecting the skin. The LCAd17 mice showed increased accumulation of apoptotic keratinocytes, monocytes, and monocytederived DCs (Fig. 5, A and B, and fig. S6 , F and G), blunted epidermal hyperplasia (Fig. 5C) , and increased epidermal permeability (Fig. 5D ) after UVR exposure. Inducible deletion in LCs (34) of ADAM17 in Langerin CreER +/− ADAM17 flox/flox mice also increased UVRinduced kerat inocyte apoptosis and monocyte accumulation (fig. S7, A to E). HB EGF treatment dampened the increased UVRinduced keratinocyte ap optosis and skin inflammation in LCAd17 mice (Fig. 5, E and F) , supporting the idea that the effect of LC ADAM17 deletion involved EGFR signals. In vitro, ADAM17 deficiency or blockade rendered LCs unable to protect keratinocytes from UVRinduced apoptosis in both murine and human systems (Fig. 5, G and H) . These results together strongly supported the idea that LCs limit UVR effects via ADAM17 and stimulating keratinocyte EGFR.
The rapid LCdependent increase in epidermal EGFR activation with UVR suggested that LC ADAM17 could be activated by UVR. To measure ADAM17 activity, we quantified the level of cellsurface tumor necrosis factor receptor 1 (TNFR1), a substrate for ADAM17 (31) . Treatment with phorbol 12myristate 13acetate (PMA), a known ADAM17 activator (31) , reduced murine LC TNFR1 in an ADAM17 dependent manner, as expected (Fig. 6A) . Similar to PMA, UVR rapidly reduced TNFR1 on both murine and human LCs (Fig. 6, A and B) . This effect was abrogated by Adam17 deletion or ADAM17 blockade (Fig. 6, A and B) . These results suggested that ADAM17 on LCs can be rapidly activated by UVR.
To examine whether the UVRinduced ADAM17 activation actually resulted in EGFR ligand cleavage and release, we col lected conditioned supernatants from UVR exposed LCs and assessed how well the supernatants induced EGFR phos phorylation in EGFRoverexpressing A431 indicator cells (fig. S8, A and B) . In con trast to supernatants from murine or human LCs that were not exposed to UVR, supernatants from UVRexposed LCs induced a robust increase in A431 cell EGFR phosphorylation, and Adam17 deletion or ADAM17 blockade abolished this effect (Fig. 6, C and D) . UVR has been shown to activate ADAM17 on ke ratinocytes (35) , and UVR exposure also caused murine keratinocytes to release more EGFR ligands, although this effect was less pronounced than that seen in the LCs ( fig. S8C ). These data further estab lished that UVR can trigger ADAM17 activation on LCs and showed that this activation can result in greater avail ability of active EGFR ligand. Together, our results show a central role for LCs and LCderived ADAM17 in vivo and UVR induced ADAM17 activation on LCs ex vivo, suggesting that there is an LC keratinocyte axis where by UVR induces LC ADAM17 activation and consequent EGFR ligand cleavage, leading to increased kerat inocyte EGFR activa tion, which limits UVRinduced keratinocyte apoptosis and skin injury.
The LC-keratinocyte axis is dysfunctional in photosensitive SLE models and human SLE We asked whether photosensitivity in SLE models, at least in part, reflected dysfunction of this LCkeratinocyte axis. The MRLFas lpr SLE model is a known photosensitive strain, developing more UVR induced skin pathology than control Balb/c and/or MRLMpJ mice (36, 37) . UVR induces increased apoptotic keratinocyte accumula tion in MRLFas lpr mice (Fig. 7A ) (36) along with skin plasma cell accumulation ( fig. S9A) . Consistent with the possibility of a dys functional LCkeratinocyte axis, MRLFas lpr mice showed reduced UVRinduced EGFR phosphorylation (Fig. 7B) .
LC numbers are comparable between MRLFas lpr mice and Balb/c controls (38) , and we asked about their ability to protect the skin. MRLFas lpr LCs showed a trend toward reduced expression of epigen, the most abundantly expressed EGFR ligand, with UVR and reduced expression of epiregulin ( fig. S9B ), a ligand with rela tively low expression (Fig. 4A) . Adam17 mRNA, on the other hand, was reduced in MRLFas lpr mice by about 70% at homeostasis and after UVR exposure (Fig. 7C) . Consistent with the reduced Adam17 expression, MRLFas lpr LCs showed no UVRinduced ADAM17 ac tivation as indicated by TNFR1 changes or release of EGFR ligands ( fig. S9, C and D) . In vitro, MRLFas lpr LCs did not limit UVR induced keratinocyte apoptosis (Fig. 7D ), whereas control LCs could limit UVR induced apoptosis of MRLFas lpr keratinocytes (Fig. 7D) , suggesting that LC dysfunction was the critical defect leading to increased UVR sensitivity in MRLFas lpr mice. These data together suggested that MRLFas lpr LCs, because of reduced ADAM17 and potentially be cause of reduced EGFR ligand expression, were unable stimulate epidermal EGFR, thus contributing to photosensitivity.
We also examined the B6.Sle1yaa model of SLE. These mice carry the Sle1 lupus susceptibility locus derived from lupusprone NZB2410 mice along with the Y chromosome autoimmune accel erator locus whose activity is attribut able to Tolllike receptor 7 duplication (39). The mice develop lymphadenopathy by 3 months (fig. S10A ), splenomegaly and autoantibody production by 4 months, and nephritis by 12 months (40) . How ever, the photosensitivity of this model is unknown. Sixweekold B6.Sle1yaa mice did not show increased UVR induced keratinocyte apoptosis ( fig. S10B ), but 8 to 12monthold B6.Sle1yaa mice did (Fig. 7E) . Upon multiday UVR treat ment, 8 to 12monthold B6.Sle1yaa mice developed skin lesions as early as 2 days, whereas B6 mice did not ( fig.  S10C ). The skin findings were associated with the presence of plasma cells in the skin (fig. S10D ). These results indi cated that diseased B6.Sle1yaa mice are photosensitive.
The 8 to 12monthold B6.Sle1yaa mice also showed reduced UVRinduced epidermal EGFR activation relative to controls (Fig. 7F) . LC numbers were unchanged, and only the EGFR ligand amphiregulin was reduced (fig. S10, E and F), but B6.Sle1yaa LCs showed reduced Adam17 mRNA expression (Fig. 7G) . Together, these data suggested that photosensitivity in both SLE models may be attributable, at least in part, to a dysfunctional LC keratinocyte axis whereby LCs are less able to produce activated EGFR ligands to stimulate keratinocyte EGFR.
We examined human SLE skin for signs of a dysfunctional LCkeratinocyte axis. Nonsunexposed, nonlesional SLE skin showed decreased LC numbers relative to healthy control skin (Fig. 7H) , suggesting an abnormality in LC func tion and a potential for reduced input of EGFR ligands. Epidermal EGFR phos phorylation was also reduced in SLE skin (Fig. 7I) . These data support the idea that the LCkeratinocyte axis is dysfunctional in human SLE. . Error bars depict SDs (A, B, and D to H) or interquartile ranges (C). *P < 0.05, **P < 0.01, ***P < 0.001 using two-tailed unpaired Student's t test (A, B, and D to H) or nonparametric nondirectional Mann-Whitney U test after one-way ANOVA (C).
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Topical EGFR ligand reduces photosensitivity in an SLE model We asked whether EGFR ligand supplementation could reduce photo sensitivity in MRLFas lpr mice. Multiday UVR exposure has been shown to increase complement and immunoglobulin deposition in skin (36) , and we observed that this regimen also led to ulcerations with a neutrophildominant infiltrate (Fig. 8, A to D, and fig. S11 , A and B). Topical treatment with HBEGF (Fig. 8A ) reduced the severity of UVRinduced skin lesions (Fig. 8, B to D, and fig. S11 , A and B) and monocyte accumulation (Fig. 8E) . Topical HBEGF also reduced germinal center B cells ( fig. S11C) and plasma cells (fig. S11D ) in skindraining lymph nodes, suggesting that modulating skin EGFR signaling may affect systemic immunity. These findings suggest that compensating for a dysfunctional LCkeratinocyte axis by providing EGFR ligand can be used as an approach to treating photosensitivity.
DISCUSSION
LCs are best known as antigenpresenting cells, and our findings here establish LCs also as direct modulators of keratinocyte function and skin integrity whereby LCs limit sensitivity to UVRinduced kerati nocyte apoptosis and skin injury. The mechanism requires LC expres sion of ADAM17, the metalloprotease that activates LC expressed EGFR ligands to stimulate epidermal EGFR. LC abnormalities may contribute to dysfunction of the LCkeratinocyte axis in SLE, leading to photosensitivity, and EGFR ligand supplementation may be an approach to treating photosensitivity ( fig. S12 ).
The LCkeratinocyte axis appears to be a stress survival mecha nism. During homeostasis, keratinocyte ADAM17 plays a major role in maintaining skin integrity and barrier function (23) , and our re sults indicating that LCs have only a modest role in maintaining epidermal EGFR phosphorylation during homeostasis are consist ent with this. In contrast, LCs and LC ADAM17 had an important role in limiting skin injury with UVR, suggesting a scenario in which, in times of stress, keratinocytes require an extra source of EGFR ligands and LCs function as this source. That LC ADAM17 responded more robustly to UVR than keratinocyte ADAM17 fur ther supported a role for LCs in providing a critical source of EGFR ligands in the setting of stress. This role in promoting survival during stress is similar to the role of DCs that we have delineated in inflamed lymph nodes and fibrotic skin (14, 15) . Murine LCs are closely related to macrophages in ontogeny but have classical DC functions (10). Our findings suggest that LCs behave as DCs in maintaining epidermal integrity in times of stress.
Our model that LCs provide EGFR ligands to stimulate kerat inocyte EGFR was supported by the UVRinduced increase in EGFR phosphorylation. In vitro, UVRinduced EGFR phosphoryl ation has been shown to involve both ligandinduced EGFR kinase activity (35, 41, 42) and reduction of protein receptortype phos phatase κ activity (43) . The inhibition of UVRinduced EGFR phos phorylation by an EGFR tyrosine kinase inhibitor in vivo supports the importance of EGFR kinase activity. Whether LCs also regulate phosphatase activity merits further study.
Our study adds to the recent developments showing rapid EGFR ligand production at barrier surfaces as a protective mechanism. , and three (C) independent experiments. Bars represent means. Error bars depict SDs. *P < 0.05, **P < 0.01, ***P < 0.001 using two-tailed unpaired Student's t test after one-way ANOVA.
Regulatory T cells and group 2 innate lymphoid cells have recently been shown to be critical sources of the EGFR ligand amphiregulin in protecting lung and colonic epithelium, respectively, during inflammation (44, 45) . In these models, amphiregulin expression was induced within days by alarmins from the injured tissues. In contrast, LCs were "immediate responders," because LCdependent epi dermal phosphoEGFR upregulation oc curred by 1 hour after UVR in vivo, and UVR could act directly on LCs to acti vate LC ADAM17 ex vivo. Whether in jured kerat inocyte signals induce the upregulation of LC epigen and amphi regulin at 24 hours and whether LCs are unique among immune cells in direct activation of ADAM17 are unknown. However, our study and that of others' together suggest that there are distinct immediate versus early layers of regula tion to protect barrier surfaces. Hatakeyama et al. (46) recently sug gested that LCs help to resolve UVR induced skin inflammation at day 5 and later after UVR exposure by ingesting and clearing apoptotic keratinocytes. We show distinct findings, focusing on immedi ate events after UVR exposure. Further more, we detected essentially no activated caspase3 + Langerin + cells at 24 hours after exposure in WT mice and in LC keratinocyte cocultures, suggesting that LC phagocytosis of apoptotic keratino cytes was minimal both in vivo and in vitro. Thus, although we do not rule out a role for LCs in clearing apoptotic ke ratinocytes at later time points, our study firmly establishes a role for LCs in lim iting keratinocyte apoptosis early on.
Our study also suggested that LCs limit monocyte recruitment to the UVR exposed skin and that accumulated mono cytes contribute to increased epidermal permeability. UVR has long been noted to deplete LCs from the skin, and this depletion correlated with myeloid cell accumulation (47) . Our results would suggest that the UVRmediated depletion of LCs caused the myeloid cell accumula tion and that stronger or chronic UVR exposure would further deplete LCs, lead ing to greater myeloid cell accumulation. EGFR activity has been shown to limit keratinocyte CCL2 expression (7), but the extent to which LCs alter chemokine ex pression by keratinocytes, fibroblasts, or endothelial cells needs to be examined more directly in future studies. Sontheimer et al. (48) recently showed that monocytes may be a major source of type I interferon a few days after UVR exposure, and it would be interesting to understand whether type I interferon increased epidermal permeability. Because UVR is also associated with immune suppression in healthy humans but increased autoimmunity in SLE patients (1, 47) , it will be inter esting to understand whether monocyte and monocytederived cells participate in differentially modulating immunity after UVR expo sure in healthy and lupus erythematosus patients. Our study is relevant for understanding photosensitivity in human disease in several ways. First, we showed that the LCkeratinocyte axis is dysfunctional in two SLE models, and the reduced EGFR phosphorylation in human SLE skin suggested that this axis may be dysfunctional and contribute to photosensitivity in human SLE. LC numbers were reduced in human SLE skin, and whether the reduced epidermal EGFR phosphorylation reflected the LC reduction, or other defects such as reduced LC ADAM17 or EGFR ligand expression, remains to be determined. Although LCindependent keratinocyte intrinsic dysfunction may also lead to reduced epidermal EGFR phosphorylation and will need to be considered, the reduced LC numbers suggest failure of LC development or survival or perhaps increased migration to draining lymph nodes and suggest that LCs may be dysfunctional in human SLE. Second, our data showed that LCs protected at least UVAmediated skin injury. Because sunlight is composed primarily of UVA (49) , our data are relevant for better understanding the mechanisms that protect against the effects of sunlight exposure in lupus patients. Further understanding of LC function and regulation in SLE will be interesting, as will under standing whether there are similar defects in photosensitivity asso ciated with other disorders (3) .
There are a few limitations of this study. Although epidermal EGFR phospho rylation is reduced in human SLE skin, we do not yet know whether human SLE LCs are less able to provide activated EGFR ligands or pro tect keratinocytes from UVR. We also do not yet understand how UVR activated ADAM17 or how LCs are dysregulated in the SLE models.
Our data suggest that topical EGFR stimulation could be a treatment to pre vent the development of photosensitive cutaneous lesions in lupus erythemato sus. The reduction in lymph node B cell responses with HBEGF suggests that EGFR stimulation could also improve the systemic aspects of photosensitivity in SLE. Although the potential for car cinogenesis should be considered (50), topical EGF is being investigated for rashes associated with the use of EGFR inhibi tors to treat lung cancer patients who are most likely immunocompromised (CinicalTrials.gov; trials NCT03051880 and NCT03047863) (51) . Furthermore, in mouse models of colitisassociated cancer, EGFR inhibited tumor develop ment, likely by improving epidermal function and reducing inflam mation (52) . Our findings suggest that EGFR stimulating agents should be investigated for photosensitivity in lupus erythematosus and potentially other autoimmune and derma tologic conditions.
MATERIALS AND METHODS
Study design
Controlled experiments were designed using mouse models, in vitro systems, and human skin. Animals were randomly assigned to ex perimental groups. Sample sizes were determined on the basis of previously published experiments using similar tissues and assays (14, 15) . No data were excluded, each experiment was performed with at least three biological replicates, and all data were reliably re produced. Investigators were not blinded to group allocation during experiments and data acquisition. During data analysis, investigators were not blinded for flow cytometry, Western blot, epidermal per meability, and mRNA experiments but were blinded for histology/ immunofluorescence and lesion measurements. Sample numbers and numbers of independent experiments are included in each figure legend. Each symbol in figures represents one mouse, human, or biological replicate. List of primary antibodies are in table S1 and secondary antibodies are in table S2. Primary data are included in table S3.
UVR treatments
In vivo, four FS40T12 sunlamps that emit UVA and UVB at a 40:60 ratio (20) were used as the UVR source. We determined 1000 J/m 2 UVR to be the minimal dose that caused visible dilation in the ears of C57BL/6J mice at 24 hours and used this dose for all experiments unless otherwise indicated. For multidose experiments with LangerinDTA mice, mice were shaved 24 hours before the first UVR exposure. SLE model mice were shaved 24 hours before the first UVR exposure and then exposed to UVR (500 J/m 2 ) for six consecutive days for Error bars depict SDs. *P < 0.05, ***P < 0.001 using two-tailed unpaired Student's t test after one-way ANOVA.
lesion development experiments. In vitro, mouse and human primary keratinocytes and LCs were exposed to UVR (500 J/m 2 ) with the same UVR lamps as above.
Statistical analyses
For analyses of experiments with more than two groups, oneway ANOVA was initially used to examine differences among groups. For data that were normally distributed according to the Shapiro Wilkes test, the ANOVA was followed by the twotailed unpaired Student's t test to assess differences between two particular groups. For data that were not normally distributed, the nondirectional non parametric MannWhiney U test was used to determine differences between two groups. For analyses of experiments with only two groups, we determined the distribution with the ShapiroWilkes test and then used the appropriate statistical test for comparison. The statistical test and measure of uncertainty used for each figure are included in the figure legend.
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